Simulect (basiliximab) 20 mg powder for solution for injection/infusion, 1 vial (Novartis) Transplant rejection prevention. Drug delivery from Europe, compliant with storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.
Display
Prevention of acute organ rejection during allogeneic organ transplantationde novoin adult children (ages 1 to 17). The drug stagnates during immunosuppressive therapy with cyclosporine (microemulsion) and corticosteroids in patients in whom, instead of panel-reactive antibodies, the level becomes less than 80% or triple support Immunosuppressive therapy with cyclosporine (microemulsion), corticosteroids and azathioprine and mycophenolate mofetil
The standard total dose is 40 mg, which is administered in two doses of 20 mg cutaneously
- Trade Name:Simulect
- Chemical Name:Basilicimab
- Dosage:20 mg
- Quantity:1
- Form of Issue:Flacon
No reviews yet